Cargando…

Mixed micelles loaded with the 5-benzylidenethiazolidine-2,4-dione derivative SKLB023 for efficient treatment of non-alcoholic steatohepatitis

Background: SKLB023, a novel 5-benzylidenethiazolidine-2,4-dione based-derivative, specifically inhibits inducible nitric oxide synthase and shows promise for treating non-alcoholic steatohepatitis (NASH). However, its poor water solubility and low bioavailability limits its clinical use. Here the d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yanping, Zhang, Ting, Liu, Qinhui, Zhang, Jinhang, Li, Rui, Pu, Shiyun, Wu, Tong, Ma, Liang, He, Jinhan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551597/ https://www.ncbi.nlm.nih.gov/pubmed/31239664 http://dx.doi.org/10.2147/IJN.S202821

Ejemplares similares

SKLB023 as an iNOS inhibitor alleviated liver fibrosis by inhibiting the TGF-beta/Smad signaling pathway
por: Zhang, Jinhang, et al.
Publicado: (2018)

Protective effects of SKLB023 on a mouse model of unilateral ureteral obstruction by the modulation of gut microbiota
por: Feng, Yanhuan, et al.
Publicado: (2018)

SKLB023 protects mice against acute liver injury by inhibiting proinflammatory cytokine production in both T cells and macrophages
por: Yu, Jia, et al.
Publicado: (2018)

SKLB023 hinders renal interstitial fibrosis in obstructive nephropathy by interfering TGF-β1/Smad3 signaling
por: Feng, Yanhuan, et al.
Publicado: (2018)

SKLB023 Blocks Joint Inflammation and Cartilage Destruction in Arthritis Models via Suppression of Nuclear Factor-Kappa B Activation in Macrophage
por: Xie, Caifeng, et al.
Publicado: (2013)

Novel Therapeutic Targets in Liver Fibrosis
por: Zhang, Jinhang, et al.
Publicado: (2021)

Montelukast Prevents Mice Against Acetaminophen-Induced Liver Injury
por: Pu, Shiyun, et al.
Publicado: (2019)

Inhibition of 5-Lipoxygenase in Hepatic Stellate Cells Alleviates Liver Fibrosis
por: Pu, Shiyun, et al.
Publicado: (2021)

MANF in POMC Neurons Promotes Brown Adipose Tissue Thermogenesis and Protects Against Diet-Induced Obesity
por: Tang, Qin, et al.
Publicado: (2022)

PEG-Derivatized Dual-Functional Nanomicelles for Improved Cancer Therapy
por: Li, Yanping, et al.
Publicado: (2019)

The diabetes medication canagliflozin promotes mitochondrial remodelling of adipocyte via the AMPK-Sirt1-Pgc-1α signalling pathway
por: Yang, Xuping, et al.
Publicado: (2020)

Sirt6 in pro-opiomelanocortin neurons controls energy metabolism by modulating leptin signaling
por: Tang, Qin, et al.
Publicado: (2020)

Farnesylthiosalicylic Acid-Loaded Albumin Nanoparticle Alleviates Renal Fibrosis by Inhibiting Ras/Raf1/p38 Signaling Pathway
por: Huang, Hui, et al.
Publicado: (2021)

Immune responses in diabetic nephropathy: Pathogenic mechanisms and therapeutic target
por: Chen, Jiahao, et al.
Publicado: (2022)

Feeding-induced hepatokine, Manf, ameliorates diet-induced obesity by promoting adipose browning via p38 MAPK pathway
por: Wu, Tong, et al.
Publicado: (2021)

SKLB188 inhibits the growth of head and neck squamous cell carcinoma by suppressing EGFR signalling
por: Barzegar, Mansoureh, et al.
Publicado: (2017)

Preclinical pharmacodynamic evaluation of drug candidate SKLB-178 in the treatment of non-small cell lung cancer
por: Zhong, Lei, et al.
Publicado: (2017)

CRELD2, endoplasmic reticulum stress, and human diseases
por: Tang, Qin, et al.
Publicado: (2023)

Irisin Is Controlled by Farnesoid X Receptor and Regulates Cholesterol Homeostasis
por: Li, Hong, et al.
Publicado: (2019)

Vous cherchez? (PRESSCUT-S-2006-023)
Publicado: (2006)

Canagliflozin Facilitates Reverse Cholesterol Transport Through Activation of AMPK/ABC Transporter Pathway
por: Zhao, Yingnan, et al.
Publicado: (2021)

The Role of Sirt6 in Obesity and Diabetes
por: Kuang, Jiangying, et al.
Publicado: (2018)

SKLB1002, a potent inhibitor of VEGF receptor 2 signaling, inhibits endothelial angiogenic function in vitro and ocular angiogenesis in vivo
por: Zhang, Qiu-Yang, et al.
Publicado: (2020)

Title unknown, CERN-ALEPH-2000-023
por: CERN. Geneva. ALEPH
Publicado: (2000)

A novel multikinase inhibitor SKLB‐YTH‐60 ameliorates inflammation and fibrosis in bleomycin‐induced lung fibrosis mouse models
por: Liu, Hongyao, et al.
Publicado: (2021)

SKLB-677, an FLT3 and Wnt/β-catenin signaling inhibitor, displays potent activity in models of FLT3-driven AML
por: Ma, Shuang, et al.
Publicado: (2015)

6-Phenyloxane-2,4-dione
por: Slater, Kara A., et al.
Publicado: (2012)

1-(4-Methoxyphenyl)imidazolidine-2,4-dione
por: Sun, Su-Xia, et al.
Publicado: (2010)

CMS ARDA Meeting, ARDA-Note-2004-023
por: CERN. Geneva
Publicado: (2004)

PW02-023 - Qualitative aspects of autoinflammatory diseases
por: Konukbay, D, et al.
Publicado: (2013)

P03-023 – Autoinflammatory diseases database in Japan
por: Kawai, T, et al.
Publicado: (2013)

P023: Transfer of noroviruses between fingers and fomites
por: Duizer, E, et al.
Publicado: (2013)

O023 Impact of weight loss of OSA pathophysiology
por: Wong, A, et al.
Publicado: (2021)

O023 Quality of Life in Central Disorders of Hypersomnolence
por: Kinder, S, et al.
Publicado: (2023)

Sirt6 Alleviated Liver Fibrosis by Deacetylating Conserved Lysine 54 on Smad2 in Hepatic Stellate Cells
por: Zhang, Jinhang, et al.
Publicado: (2020)

A novel orally available Syk/Src/Jak2 inhibitor, SKLB-850, showed potent anti-tumor activities in B cell lymphoma (BCL) models
por: Zhang, Nannan, et al.
Publicado: (2017)

5-Isopropylimidazolidine-2,4-dione monohydrate
por: Abdel-Aziz, Alaa A.-M., et al.
Publicado: (2012)

Descriptors for Pentane-2,4-dione and Its Derivatives
por: Abraham, Michael H., et al.
Publicado: (2017)

P01-023 – Leukocytoclastic vasculitis in a patient with FMF
por: Taylan, A
Publicado: (2013)

P1009: SKLB054, A NOVEL JAK2 INHIBITOR, POTENTLY TREATS MYELOPROLIFERATIVE NEOPLASM WITH JAK2V617F MUTATION
por: Zhao, Ailin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1ntn3hdpr2lve363fqkr7dgoqt